新城疫病毒复制对其溶瘤作用影响的初步分析

doi:10.11843/j.issn.0366-6964.2020.04.015

畜牧兽医学报 ›› 2020, Vol. 51 ›› Issue (4): 794-800.doi: 10.11843/j.issn.0366-6964.2020.04.015

新城疫病毒复制对其溶瘤作用影响的初步分析

吴寒光, 孙军峰, 梁雨萌, 刘胜旺*, 李海*

中国农业科学院哈尔滨兽医研究所兽医生物技术国家重点实验室/禽呼吸道传染病创新团队, 哈尔滨 150069

收稿日期:2019-10-29 出版日期:2020-04-25 发布日期:2020-04-21
通讯作者: 刘胜旺,主要从事动物传染病及其病原分子流行病学研究,E-mail:liushengwang@caas.cn;李海,主要从事病原与宿主互作机制研究,E-mail:lihai@caas.cn
作者简介:吴寒光(1992-),男,河南舞阳人,硕士生,主要从事溶瘤病毒研究,E-mail:whg2020@qq.com
基金资助:
现代农业蛋鸡产业技术体系项目（CARS-40-K18）；中国农业科学院“青年英才计划”项目（CAASQNYC-KYYJ-56）

Role of Viral Replication in the Oncolysis of Newcastle Disease Virus

WU Hanguang, SUN Junfeng, LIANG Yumeng, LIU Shengwang*, LI Hai*

Division of Avian Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China

Received:2019-10-29 Online:2020-04-25 Published:2020-04-21

摘要/Abstract

摘要： 本研究旨在明确新城疫病毒（NDV）溶瘤作用是否依赖其复制水平，并改进NDV溶瘤机制研究模型。以NDV疫苗株LaSota感染人肿瘤细胞系HCT116、A549和人非肿瘤细胞系HEK293T为研究模型；RT-qPCR检测NDV在各细胞系的基因组复制水平；Western blot检测NDV在各细胞系的蛋白表达水平；利用流式细胞术检测NDV感染对各细胞系的细胞周期和细胞凋亡的影响。结果表明，NDV在三个细胞系内的基因组复制水平和蛋白表达水平没有显著差异，但对三个细胞系的溶瘤作用存在明显差异；进一步流式细胞术检测发现，NDV感染能诱发HEK293T和HCT116的细胞周期发生G1期停滞，但对A549的细胞周期没有明显影响；此外，NDV感染24 h后，A549细胞以早期凋亡为主，而HCT116细胞以坏死/晚期细胞凋亡为主。NDV的溶瘤作用并不依赖于其复制水平，而且NDV对不同类型肿瘤细胞的溶瘤作用存在不同机制。

关键词: 新城疫病毒, 复制, 溶瘤病毒, 细胞周期, 细胞凋亡

Abstract: The aim of this study was to determine the effect of the replication level of Newcastle disease virus (NDV) on its oncolytic effect and to improve the research model for studying oncolytic mechanism of NDV. The human tumor cell line HCT116, A549 and the human non-tumor cell line HEK293T were infected with the NDV vaccine strain LaSota; the replication levels of viral genome in above mentioned cell lines were detected by NDV specific RT-qPCR; the expression levels of viral protein in above mentioned cell lines were assayed by Western blot; the effects of NDV infection on cell cycle and apoptosis of above mentioned cell lines were investigated using flow cytometry. The results revealed similar levels of viral replication but distinct oncolytic effects of NDV among these three cell lines; further flow cytometry showed that NDV infection induced G1 phase arrest in HEK293T and HCT116 but not in A549; in addition, NDV mainly induced early apoptosis in A549 but necrosis/late apoptosis in HCT116. The oncolytic effect of NDV does not depend on its replication levels, and NDV kills human tumor cells by cell type-specific mechanisms.

Key words: Newcastle disease virus, replication, oncolytic virus, cell cycle, apoptosis

中图分类号:

S852.659.5

吴寒光, 孙军峰, 梁雨萌, 刘胜旺, 李海. 新城疫病毒复制对其溶瘤作用影响的初步分析[J]. 畜牧兽医学报, 2020, 51(4): 794-800.

WU Hanguang, SUN Junfeng, LIANG Yumeng, LIU Shengwang, LI Hai. Role of Viral Replication in the Oncolysis of Newcastle Disease Virus[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(4): 794-800.

参考文献 30

[1]	TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012[J]. CA:A Cancer J Clin, 2015, 65(2):87-108.
[2]	YE J X, XU J, LI Y, et al. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway[J]. Mol Oncol, 2017, 11(9):1208-1224.
[3]	DE MUNCK J, BINKS A, MCNEISH I A, et al. Oncolytic virus-induced cell death and immunity:a match made in heaven?[J]. J Leukoc Biol, 2017, 102(3):631-643.
[4]	FUKUHARA H, INO Y, TODO T. Oncolytic virus therapy:a new era of cancer treatment at dawn[J]. Cancer Sci, 2016, 107(10):1373-1379.
[5]	FOUNTZILAS C, PATEL S, MAHALINGAM D. Review:oncolytic virotherapy, updates and future directions[J]. Oncotarget, 2017, 8(60):102617-102639.
[6]	POL G J, LÉVESQUE S, WORKENHE S T, et al. Trial watch:oncolytic viro-immunotherapy of hematologic and solid tumors[J]. Oncoimmunology, 2018, 7(12):e1503032.
[7]	GOLDUFSKY J, SIVENDRAN S, HARCHARIK S, et al. Oncolytic virus therapy for cancer[J]. Oncolytic Virother, 2013, 2:31-46.
[8]	DOCK G. The influence of complicating diseases upon leukaemia[J]. Am J Med Sci, 1904, 127(4):563-592.
[9]	DE PACE N G. Sulla scomparsa di un enorme cancro vegetante del callo dell'utero senza cura chirurgica[J]. Ginecologia, 1912, 9:82-88.
[10]	BIERMAN H R, CRILE D M, DOD K S, et al. Remissions in leukemia of childhood following acute infectious disease:staphylococcus and streptococcus, varicella, and feline panleukopenias[J]. Cancer, 1953, 6(3):591-605.
[11]	HAMID O, HOFFNER B, GASAL E, et al. Oncolytic immunotherapy:unlocking the potential of viruses to help target cancer[J]. Cancer Immunol, Immunother, 2017, 66(10):1249-1264.
[12]	MARTUZA R L, MALICK A, MARKERT J M, et al. Experimental therapy of human glioma by means of a genetically engineered virus mutant[J]. Science, 1991, 252(5007):854-856.
[13]	KELLY E, RUSSELL S J. History of oncolytic viruses:genesis to genetic engineering[J]. Mol Ther, 2007, 15(4):651-659.
[14]	GARBER K. China approves world's first oncolytic virus therapy for cancer treatment[J]. J Natl Cancer Inst, 2006, 98(5):298-300.
[15]	CORRIGAN P A, BEAULIEU C, PATEL R B, et al. Talimogene laherparepvec:an oncolytic virus therapy for melanoma[J]. Ann Pharmacother, 2017, 51(8):675-681.
[16]	GANAR K, DAS M, SINHA S, et al. Newcastle disease virus:current status and our understanding[J]. Virus Res, 2014, 184:71-81.
[17]	ALDERS R G. Making Newcastle disease vaccines available at village level[J]. Vet Rec, 2014, 174(20):502-503.
[18]	CASSEL W A, GARRETT R E. Newcastle disease virus as an antineoplastic agent[J]. Cancer, 1965, 18(7):863-868.
[19]	ALEXANDER D J. Newcastle disease virus-an avian paramyxovirus[M]//ALEXANDER D J. Newcastle Disease. Boston:Springer, 1988.
[20]	CHARAN S, MAHAJAN V M, AGARWAL L P. Newcastle disease virus antibodies in human sera[J]. Indian J Med Res, 1981, 73(3):303-307.
[21]	ZHAO H, PEETERS B P H. Recombinant Newcastle disease virus as a viral vector:effect of genomic location of foreign gene on gene expression and virus replication[J]. J Gen Virol, 2003, 84(4):781-788.
[22]	CHIOCCA E A, RABKIN S D. Oncolytic viruses and their application to cancer immunotherapy[J]. Cancer Immunol Res, 2014, 2(4):295-300.
[23]	SINKOVICS J G, HORVATH J C. Newcastle disease virus (NDV):brief history of its oncolytic strains[J]. J Clin Virol, 2000, 16(1):1-15.
[24]	PARK M S, GARCÍA-SASTRE A, CROS J F, et al. Newcastle disease virus v protein is a determinant of host range restriction[J]. J Virol, 2003, 77(17):9522-9532.
[25]	WILDEN H, FOURNIER P, ZAWATZKY R, et al. Expression of RIG-I, IRF3, IFN-β and IRF7 determines resistance or susceptibility of cells to infection by Newcastle disease virus[J]. Int J Oncol, 2009, 34(4):971-982.
[26]	ELANKUMARAN S, CHAVAN V, QIAO D, et al. Type I interferon-sensitive recombinant Newcastle disease virus for oncolytic virotherapy[J]. J Virol, 2010, 84(8):3835-3844.
[27]	MANSOUR M, PALESE P, ZAMARIN D. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells[J]. J Virol, 2011, 85(12):6015-6023.
[28]	REICHARD K W, LORENCE R M, CASCINO C J, et al. Newcastle disease virus selectively kills human tumor cells[J]. J Surg Res, 1992, 52(5):448-453.
[29]	PHUANGSAB A, LORENCE R M, REICHARD K W, et al. Newcastle disease virus therapy of human tumor xenografts:antitumor effects of local or systemic administration[J]. Cancer Lett, 2001, 172(1):27-36.
[30]	ALLISON K H, SLEDGE JR G W. Heterogeneity and cancer[J]. Oncology (Williston Park), 2014, 28(9):772-778.

新城疫病毒复制对其溶瘤作用影响的初步分析

Role of Viral Replication in the Oncolysis of Newcastle Disease Virus

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

编辑推荐

Metrics

本文评价

[1]	宋雯妍, 张瀚文, 吴澳迪, 张丽燕, 刘照, 叶桐桐, 陈创夫, 盛金良. 猪繁殖与呼吸综合征病毒GP5蛋白纳米抗体的筛选及其对病毒复制的抑制效应[J]. 畜牧兽医学报, 2024, 55(1): 258-270.
[2]	王婉洁, 陈南珠, 邹惠影, 周心仪, 郝海生, 庞云渭, 朱化彬, 赵学明, 余大为, 杜卫华. 过表达组蛋白甲基转移酶ASH1L对牛卵丘细胞增殖和凋亡的影响[J]. 畜牧兽医学报, 2023, 54(8): 3358-3368.
[3]	安琪, 于嘉霖, 吴晓玲, 邓光存. 谷氨酰胺对BCG诱导小鼠传代巨噬细胞凋亡的调控作用[J]. 畜牧兽医学报, 2023, 54(7): 3054-3063.
[4]	方源, 侯巧弟, 项超辉, 赵红奕, 齐雪峰. IFITM3对小反刍兽疫病毒在山羊子宫内膜上皮细胞中增殖的调控效应[J]. 畜牧兽医学报, 2023, 54(5): 2200-2207.
[5]	但一昕, 杨璐, 向华, 张焕容, 任玉鹏, 杨发龙, 何翃闳, 朱江江. BIRC5对山羊睾丸细胞周期、凋亡的影响[J]. 畜牧兽医学报, 2023, 54(4): 1511-1524.
[6]	陈永平, 寇玉红, 焦文静, 侯晓昱, 范宏刚. 辅酶Q10改善LPS诱导小鼠急性肺损伤的效应分析[J]. 畜牧兽医学报, 2023, 54(4): 1730-1741.
[7]	王岚, 何明宇, 张敏, 丁军涛. MicroRNA调控抗病毒免疫和病毒复制[J]. 畜牧兽医学报, 2023, 54(2): 463-472.
[8]	陈俊贞, 权冉, 付强, 葛丽娟, 袁圆圆, 张成远, 李建林, 史慧君. 热休克蛋白HSP90B1影响牛病毒性腹泻病毒复制的研究[J]. 畜牧兽医学报, 2023, 54(2): 683-693.
[9]	杨成迎, 汪锴, 黄子晴, 林海烂, 王乃秀, 李雨航, 刘炎青, 刘煜萱, 朱燕, 何道领, 陈红跃, 甘玲. 壳寡糖对仔猪脑海马氧化应激的抑制作用及机制研究[J]. 畜牧兽医学报, 2023, 54(2): 744-756.
[10]	薛鸿雁, 杨孟雨, 杨欢, 董丽君, 蔡霞清, 赵泽民, 王鲜忠. ALOX15B-JNK在热应激诱导支持细胞氧化应激和凋亡中的作用[J]. 畜牧兽医学报, 2023, 54(12): 5056-5065.
[11]	李广兴, 陈阳, 陈凯婷, 武梦林, 张迪, 黄小丹. 邻苯二甲酸二-2-乙基己酯通过ROS/PTEN/PI3K/AKT轴诱导HD11细胞凋亡和程序性坏死[J]. 畜牧兽医学报, 2023, 54(12): 5240-5251.
[12]	杨梦然, 杨成林, 吴悠, 王思琪, 孔祥祎, 宁灿, 肖文广, 范慧, 邬静, 袁志航. 桔青霉素诱导小鼠肠道屏障功能障碍的机制研究[J]. 畜牧兽医学报, 2023, 54(11): 4805-4816.
[13]	贾艺泉, 于梦婷, 刘卫容, 方守国, 章松柏. 黄芩苷通过促进Ⅰ型干扰素表达抑制鸡传染性支气管炎病毒复制[J]. 畜牧兽医学报, 2023, 54(11): 4839-4850.
[14]	杨雪, 杨超, 王拙, 唐德富, 张丽, 余群力. 日粮添加酵母硒对鸡肉线粒体氧化损伤及细胞凋亡的影响[J]. 畜牧兽医学报, 2022, 53(9): 3079-3092.
[15]	李杨, 周栋, 尹彦龙, 张广冻, 相彩霞, 支飞杰, 白芙蓉, 林鹏飞, 靳亚平, 王爱华. 布鲁氏菌OMP16对RAW264.7细胞凋亡与免疫活性的影响[J]. 畜牧兽医学报, 2022, 53(8): 2642-2651.